Equity Clock

Arithmetic Average Seasonal Chart

Geometric Average Seasonal Chart

NEO Relative to the S&P 500

NEO Relative to the Sector

% of Revenue Generated in Each Quarter

% of Free Cash Flow Generated in Each Quarter

% of Net Income Generated in Each Quarter

Seasonal Chart Analysis

Analysis of the NeoGenomics, Inc. (NASD:NEO) seasonal charts above shows that a Buy Date of January 7 and a Sell Date of May 15 has resulted in a geometric average return of 32.44% above the benchmark rate of the S&P 500 Total Return Index over the past 18 years. This seasonal timeframe has shown positive results compared to the benchmark in 14 of those periods. This is a good rate of success and the return outperforms the relative buy-and-hold performance of the stock over the past 18 years by an average of 1.99% per year.

The seasonal timeframe correlates Poorly with the period of seasonal strength for the Healthcare sector, which runs from April 25 to December 4. The seasonal chart for the broad sector is available via the following link: Healthcare Sector Seasonal Chart.

NeoGenomics Inc operates a network of cancer-focused genetic testing laboratories in the United States as well as a laboratory in Switzerland. The company operates into two segments namely Clinical Services and Pharma Services. It offers types of genetic and molecular testing services namely Cytogenetics, Fluorescence In-Situ Hybridization, Flow cytometry, Immunohistochemistry, Molecular testing, Pathology consultation. The company generates revenue from Clinical Services.

To download NEO seasonal chart data, please log in or Subscribe.

Stocks mentioned in this post: NEO